Additional Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Northwestern University
    Chicago IL. 60611
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    AdventHealth Orlando
    Orlando FL. 32803
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Alabama at Birmingham
    Birmingham AL. 35205
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    National Jewish Health
    Denver CO. 80206
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Minnesota
    Minneapolis MN. 55455
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Kentucky
    Lexington KY. 40536
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Michigan - Michigan Medicine
    Ann Arbor MI. 48109-5360
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute
    Phoenix AZ. 85013
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    CHI Health Creighton University Medical Center - Bergan Mercy
    Omaha NE. 68124
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Illinois Health
    Chicago IL. 60612
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Indiana University Health Methodist Hospital
    Indianapolis IN. 46202
    View Details

  • Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

    Snyder Building 480 Ray C. Hunt Drive
    Charlottesville VA. 22908
    View Details

  • Inspiratory Work of Breathing Before and After Extubation

    Toronto General Hospital, University Health Network
    Toronto ON. M5G2C4
    View Details

  • Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

    Weill Cornell Medicine
    New York NY. 10065
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Atrium Health Wake Forest School of Medicine
    Winston-Salem NC. 27157
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Baylor Scott and White Health
    Temple TX. 76508
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    University of Southern California
    Los Angeles CA. 90033
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Indiana University
    Indianapolis IN. 46202
    View Details